Actively Recruiting
Study Assessing CLENPIQ as Bowel Preparation for Pediatric Colonoscopy
Led by Ferring Pharmaceuticals · Updated on 2026-04-09
30
Participants Needed
5
Research Sites
257 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Bowel preparation for pediatric colonoscopy.
CONDITIONS
Official Title
Study Assessing CLENPIQ as Bowel Preparation for Pediatric Colonoscopy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female aged 2 years to less than 9 years scheduled for elective colonoscopy
- Weight of at least 10 kg (22 lbs)
- Average of three or more spontaneous bowel movements per week for 1 month before colonoscopy
- Written informed consent from parent(s)/caregiver(s)/guardian(s) and assent if applicable
You will not qualify if you...
- History of significant liver, cardiovascular, or kidney disease including recent or ongoing low urine output
- Acute surgical abdominal conditions during screening such as obstruction or perforation
- Clinically significant abdominal pain during screening
- Severe acute inflammatory bowel disease during screening
- Prior colorectal surgery except appendectomy or polyp removal
- History of colon diseases like Hirschsprung disease, volvulus, idiopathic pseudo-obstruction, or hypomotility syndrome
- History or ongoing intestinal ulceration, toxic megacolon, or other toxic colitis
- History of upper gastrointestinal disorders such as active ulcers, pyloric stenosis, gastroparesis, or ileus
- History of upper gastrointestinal surgery excluding gallbladder removal
- Chronic or severe nausea or vomiting during screening
- Moderate to severe dehydration during screening
- Prior epileptic seizures or convulsions
- Relevant neurological events during screening
- Abnormal kidney function tests or electrolyte levels during screening
- High magnesium levels during screening
- Use of prohibited medications before the procedure including lithium, laxatives, drugs causing constipation, antidiarrheals, or oral iron
- Participation in another investigational drug trial recently
- Any abnormal medical findings that might increase risk in the opinion of investigators
- Hypersensitivity to any trial medication ingredients
- Inability to follow dietary restrictions or fluid requirements before and after study drug administration
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 5 locations
1
Ferring Investigational Site
Mobile, Alabama, United States, 36604
Actively Recruiting
2
Ferring Investigational Site
San Diego, California, United States, 92123
Actively Recruiting
3
Ferring Investigational Site
Baltimore, Maryland, United States, 21201
Actively Recruiting
4
Ferring Investigational Site
Baltimore, Maryland, United States, 21287
Actively Recruiting
5
Ferring Investigational Site
The Bronx, New York, United States, 10467
Actively Recruiting
Research Team
G
Global Clinical Compliance
CONTACT
G
Global Clinical Compliance
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SCREENING
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here